NCT05466955

Brief Summary

STABLE is a stepped-wedge cluster randomised controlled trial and its primary aim is to determine whether the provision of spectacles for the correction of myopia can reduce the average number of crash-near-crash (CNC) events among eligible motorcycle drivers in Vietnam as measured under naturalistic driving conditions with the Data Acquisition System (DAS). STABLE is designed to assess the impact of vision correction on the safety of road users in a a Low and Middle income countries (LMIC) setting. A positive trial outcome would demonstrate the safety benefits of vision correction and would create pressure for tighter regulation of drivers' vision and the promotion of vision correction. The study will be conducted in the peri-urban universities in Ho Chi Minh City, Vietnam and 625 students from five universities will be recruited into the trial. Before conducting the main trial, a pilot of 35 students will be recruited to test DAS and build CNC dictionary. Duration of the trial is 33 months from enrolment to completion of primary analysis, with 18 months for data collection. Study participants can be both male and female motorcycle drivers aged 18 to 23 years years with at least one year of driving experience; they must use their motorcycle as their primary means of transport; drive at least 25 km per week and present with un- or under-corrected myopia that can be corrected with spectacles. Participants with any ocular or systemic abnormality affecting vision, other than un-or under-corrected myopia will be excluded from the trial. STABLE's primary outcome is CNC events per 1,000 km driven the DAS mounted to the motorcycles of trial participants. An interim analysis of the primary outcome will take place 9 months after data collection begins. The interim analysis will be reviewed by the trial's Data Monitoring and Ethics Committee. Unless a change is needed because of this review, the trial's primary analysis will take place 18 months after the DAS units are fitted to participants' motorcycle). Compliance with study glasses; self-reported visual function (driving-adapted Visual Function Questionnaire-25 \[VFQ-25\]); Dula Dangerous Driving Index (DDDI), for all crashes; self-reported CNC events for comparison with recorded CNC events and total delivery cost per CNC event avoided with the intervention (indicator of cost-effectiveness).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
625

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Sep 2024Dec 2027

First Submitted

Initial submission to the registry

July 11, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 20, 2022

Completed
2.2 years until next milestone

Study Start

First participant enrolled

September 22, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 17, 2025

Status Verified

July 1, 2025

Enrollment Period

1.7 years

First QC Date

July 11, 2022

Last Update Submit

July 14, 2025

Conditions

Keywords

crash eventsnear-crash eventsmyopiamotorcycle drivers

Outcome Measures

Primary Outcomes (1)

  • Crash and near-crash (CNC) events per 1,000 km driven

    CNC events as measured by Global Positioning System (GPS) and a gyroscopic sensor-video data-acquisition system (DAS) mounted to the motorcycles of trial participants.

    up to18 months

Secondary Outcomes (4)

  • Cost-effectiveness

    18 months, Collected at the end of the trial.

  • Self-reported crashes

    up to 18 months

  • Spectacle compliance

    up to 18 months

  • Visual Function

    VFQ-25 is administered at baseline and one month after receiving glasses.

Study Arms (2)

Free eye glasses for un or under-corrected myopia

EXPERIMENTAL

Free eyeglasses for the correction of uncorrected myopia will be provided to participants at the time of enrolment into the intervention group.

Device: Free eye glasses for un or under-corrected myopia

Control-No treatment

NO INTERVENTION

Participants in the control period will not have glasses but the SW-CRT design means that all trial participants with uncorrected myopia will receive free glasses by the trials' completion, and no participant will have glasses withheld after being diagnosed with un- or under-corrected myopia.

Interventions

All participants randomised to the intervention group will be provided with free eye glasses

Free eye glasses for un or under-corrected myopia

Eligibility Criteria

Age18 Years - 23 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Students from selected universities will be eligible to participate if they:
  • are aged 18 to 23 years
  • have at least one year or more years of driving experience
  • are the sole user of their motorcycle
  • use their motorcycle as their primary means of transport
  • drive at least 25 km per week (self-report)
  • hold a valid driving license if their motorcycle has an engine capacity \>50cc
  • Participants will be eligible for assignment to transition into the intervention group if, during the STABLE clinical examination, they are found to have:
  • presenting distance visual acuity \<= 6/12 in the better-seeing eye due to un- or under-corrected myopia,
  • vision correctable to 6/7.5 or better in both eyes
  • at least 0.5 Dioptre of myopia

You may not qualify if:

  • Individuals with any ocular or systemic abnormalities affecting vision will be ineligible to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, Hong Bang Ward 11, 217, Vietnam

RECRUITING

Related Publications (59)

  • Peden M, Oyegbite K, Ozanne-Smith J, Hyder AA, Branche C, Rahman AKMF, Rivara F, Bartolomeos K, editors. World Report on Child Injury Prevention. Geneva: World Health Organization; 2008. Available from http://www.ncbi.nlm.nih.gov/books/NBK310641/

    PMID: 26269872BACKGROUND
  • Dolgin E. The myopia boom. Nature. 2015 Mar 19;519(7543):276-8. doi: 10.1038/519276a. No abstract available.

    PMID: 25788077BACKGROUND
  • Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA. The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res. 2018 Jan;62:134-149. doi: 10.1016/j.preteyeres.2017.09.004. Epub 2017 Sep 23.

    PMID: 28951126BACKGROUND
  • Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006. Epub 2016 Feb 11.

    PMID: 26875007BACKGROUND
  • Paudel P, Ramson P, Naduvilath T, Wilson D, Phuong HT, Ho SM, Giap NV. Prevalence of vision impairment and refractive error in school children in Ba Ria - Vung Tau province, Vietnam. Clin Exp Ophthalmol. 2014 Apr;42(3):217-26. doi: 10.1111/ceo.12273. Epub 2014 Jan 28.

    PMID: 24299145BACKGROUND
  • Limburg H, Gilbert C, Hon DN, Dung NC, Hoang TH. Prevalence and causes of blindness in children in Vietnam. Ophthalmology. 2012 Feb;119(2):355-61. doi: 10.1016/j.ophtha.2011.07.037. Epub 2011 Oct 27.

    PMID: 22035577BACKGROUND
  • Ma X, Zhou Z, Yi H, Pang X, Shi Y, Chen Q, Meltzer ME, le Cessie S, He M, Rozelle S, Liu Y, Congdon N. Effect of providing free glasses on children's educational outcomes in China: cluster randomized controlled trial. BMJ. 2014 Sep 23;349:g5740. doi: 10.1136/bmj.g5740.

    PMID: 25249453BACKGROUND
  • Wang X, Yi H, Lu L, Zhang L, Ma X, Jin L, Zhang H, Naidoo KS, Minto H, Zou H, Rozelle S, Congdon N. Population Prevalence of Need for Spectacles and Spectacle Ownership Among Urban Migrant Children in Eastern China. JAMA Ophthalmol. 2015 Dec;133(12):1399-406. doi: 10.1001/jamaophthalmol.2015.3513.

    PMID: 26426113BACKGROUND
  • Piyasena P, Olvera-Herrera VO, Chan VF, Clarke M, Wright DM, MacKenzie G, Virgili G, Congdon N. Vision impairment and traffic safety outcomes in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Glob Health. 2021 Oct;9(10):e1411-e1422. doi: 10.1016/S2214-109X(21)00303-X. Epub 2021 Aug 16.

    PMID: 34411516BACKGROUND
  • Pepple G, Adio A. Visual function of drivers and its relationship to road traffic accidents in Urban Africa. Springerplus. 2014 Jan 24;3:47. doi: 10.1186/2193-1801-3-47. eCollection 2014.

    PMID: 24505558BACKGROUND
  • Swain TA, McGwin G Jr, Wood JM, Antin JF, Owsley C. Naturalistic Driving Techniques and Association of Visual Risk Factors With At-Fault Crashes and Near Crashes by Older Drivers With Vision Impairment. JAMA Ophthalmol. 2021 Jun 1;139(6):639-645. doi: 10.1001/jamaophthalmol.2021.0862.

    PMID: 33914022BACKGROUND
  • Hanowski RJ, Hickman JS, Olson RL, Bocanegra J. Evaluating the 2003 revised hours-of-service regulations for truck drivers: the impact of time-on-task on critical incident risk. Accid Anal Prev. 2009 Mar;41(2):268-75. doi: 10.1016/j.aap.2008.11.007. Epub 2008 Dec 25.

    PMID: 19245885BACKGROUND
  • Simons-Morton BG, Gershon P, O'Brien F, Gensler G, Klauer SG, Ehsani JP, Zhu C, Gore-Langton RE, Dingus TA. Crash rates over time among younger and older drivers in the SHRP 2 naturalistic driving study. J Safety Res. 2020 Jun;73:245-251. doi: 10.1016/j.jsr.2020.03.001. Epub 2020 Apr 8.

    PMID: 32563399BACKGROUND
  • Klauer SG, Guo F, Simons-Morton BG, Ouimet MC, Lee SE, Dingus TA. Distracted driving and risk of road crashes among novice and experienced drivers. N Engl J Med. 2014 Jan 2;370(1):54-9. doi: 10.1056/NEJMsa1204142.

    PMID: 24382065BACKGROUND
  • Guo F, Klauer SG, Fang Y, Hankey JM, Antin JF, Perez MA, Lee SE, Dingus TA. The effects of age on crash risk associated with driver distraction. Int J Epidemiol. 2017 Feb 1;46(1):258-265. doi: 10.1093/ije/dyw234.

    PMID: 28338711BACKGROUND
  • Hemming K, Taljaard M. Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice? Int J Epidemiol. 2020 Jun 1;49(3):1043-1052. doi: 10.1093/ije/dyaa077.

    PMID: 32386407BACKGROUND
  • Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, Dixon-Woods M, Aldcroft A, Doussau A, Grayling M, Kristunas C, Goldstein CE, Campbell MK, Girling A, Eldridge S, Campbell MJ, Lilford RJ, Weijer C, Forbes AB, Grimshaw JM. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614.

    PMID: 30413417BACKGROUND
  • Hemming K, Taljaard M, Grimshaw J. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials. Trials. 2019 Jan 18;20(1):68. doi: 10.1186/s13063-018-3116-3.

    PMID: 30658677BACKGROUND
  • Willemsen J, Dula CS, Declercq F, Verhaeghe P. The Dula Dangerous Driving Index: an investigation of reliability and validity across cultures. Accid Anal Prev. 2008 Mar;40(2):798-806. doi: 10.1016/j.aap.2007.09.019. Epub 2007 Oct 8.

    PMID: 18329435BACKGROUND
  • Espie S, Boubezoul A, Aupetit S, Bouaziz S. Data collection and processing tools for naturalistic study of powered two-wheelers users' behaviours. Accid Anal Prev. 2013 Sep;58:330-9. doi: 10.1016/j.aap.2013.03.012. Epub 2013 Mar 29.

    PMID: 23659861BACKGROUND
  • Foss RD, Goodwin AH. Distracted driver behaviors and distracting conditions among adolescent drivers: findings from a naturalistic driving study. J Adolesc Health. 2014 May;54(5 Suppl):S50-60. doi: 10.1016/j.jadohealth.2014.01.005.

    PMID: 24759441BACKGROUND
  • Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ. 2012 Sep 14;345:e5840. doi: 10.1136/bmj.e5840.

    PMID: 22983531BACKGROUND
  • Permutt T. Testing for imbalance of covariates in controlled experiments. Stat Med. 1990 Dec;9(12):1455-62. doi: 10.1002/sim.4780091209.

    PMID: 2281233BACKGROUND
  • Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002 Oct 15;21(19):2917-30. doi: 10.1002/sim.1296.

    PMID: 12325108BACKGROUND
  • Senn SJ. Covariate imbalance and random allocation in clinical trials. Stat Med. 1989 Apr;8(4):467-75. doi: 10.1002/sim.4780080410.

    PMID: 2727470BACKGROUND
  • Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000 Aug;23(4):334-40. doi: 10.1002/1098-240x(200008)23:43.0.co;2-g.

    PMID: 10940958BACKGROUND
  • Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018 Nov 19;18(1):143. doi: 10.1186/s12874-018-0611-x.

    PMID: 30453902BACKGROUND
  • Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C; WHO/NIH Joint Project. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010 Nov 1;88(11):815-23. doi: 10.2471/BLT.09.067231. Epub 2010 May 20.

    PMID: 21076562BACKGROUND
  • Erlingsson C, Brysiewicz P. A hands-on guide to doing content analysis. Afr J Emerg Med. 2017 Sep;7(3):93-99. doi: 10.1016/j.afjem.2017.08.001. Epub 2017 Aug 21.

    PMID: 30456117BACKGROUND
  • Guerrero-Castaneda RF, Menezes TMO, Ojeda-Vargas MG. Characteristics of the phenomenological interview in nursing research. Rev Gaucha Enferm. 2017 Jul 6;38(2):e67458. doi: 10.1590/1983-1447.2017.02.67458. English, Spanish.

    PMID: 28700028BACKGROUND
  • Peat G, Rodriguez A, Smith J. Interpretive phenomenological analysis applied to healthcare research. Evid Based Nurs. 2019 Jan;22(1):7-9. doi: 10.1136/ebnurs-2018-103017. Epub 2018 Dec 1. No abstract available.

    PMID: 30504450BACKGROUND
  • Akl EA, Treweek S, Foy R, Francis J, Oxman AD; ReBEQI group. NorthStar, a support tool for the design and evaluation of quality improvement interventions in healthcare. Implement Sci. 2007 Jun 26;2:19. doi: 10.1186/1748-5908-2-19.

    PMID: 17594495BACKGROUND
  • Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015 Mar 19;350:h1258. doi: 10.1136/bmj.h1258.

    PMID: 25791983BACKGROUND
  • Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj.a1655.

    PMID: 18824488BACKGROUND
  • Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013 Jan 12;14:15. doi: 10.1186/1745-6215-14-15.

    PMID: 23311722BACKGROUND
  • Forero R, Nahidi S, De Costa J, Mohsin M, Fitzgerald G, Gibson N, McCarthy S, Aboagye-Sarfo P. Application of four-dimension criteria to assess rigour of qualitative research in emergency medicine. BMC Health Serv Res. 2018 Feb 17;18(1):120. doi: 10.1186/s12913-018-2915-2.

    PMID: 29454350BACKGROUND
  • Hadi MA, Jose Closs S. Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int J Clin Pharm. 2016 Jun;38(3):641-6. doi: 10.1007/s11096-015-0237-6. Epub 2015 Dec 14.

    PMID: 26666909BACKGROUND
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007 Dec;19(6):349-57. doi: 10.1093/intqhc/mzm042. Epub 2007 Sep 14.

    PMID: 17872937BACKGROUND
  • Tudur Smith C, Hopkins C, Sydes MR, Woolfall K, Clarke M, Murray G, Williamson P. How should individual participant data (IPD) from publicly funded clinical trials be shared? BMC Med. 2015 Dec 17;13:298. doi: 10.1186/s12916-015-0532-z.

    PMID: 26675031BACKGROUND
  • Tudur Smith C, Nevitt S, Appelbe D, Appleton R, Dixon P, Harrison J, Marson A, Williamson P, Tremain E. Resource implications of preparing individual participant data from a clinical trial to share with external researchers. Trials. 2017 Jul 17;18(1):319. doi: 10.1186/s13063-017-2067-4.

    PMID: 28712359BACKGROUND
  • World Health Organization. Global status report on road safety 2015. Geneva: World Health Organization; 2015

    BACKGROUND
  • United Nations General Assembly. Transforming our world : the 2030 Agenda for Sustainable Development: UN General Assembly; 2015

    BACKGROUND
  • United Nations General Assembly. Road Safety Performance Review-Vietnam. New York: United Nation; 2018.

    BACKGROUND
  • Hoàng Ngọc Chương HHK, Nguyễn Tịnh Anh. Assessment of freshman visual acuity and refractive error at the National Technical College of Medicine. Da Nang: University of Da Nang; 2010

    BACKGROUND
  • Cochrane Effective Practice and Organization of Care. EPOC Low and middle income country filters. 2020. https://epoc.cochrane.org/lmic-filters (accessed 18 March 2021)

    BACKGROUND
  • World Health Organization. Global status report on road safety 2018. Geneva: World Health Organization; 2018

    BACKGROUND
  • Ibrahim MKAMJ, H. Abdul Manan, M.M. Hanowski, R.J. Roaming the Virtual Lanes: Motorcyclists' Lane Filtering- Splitting Manoeuvres and Exposure to Road Crashes. Journal of the Society of Automotive Engineers Malaysia 2019; 3(2): 229-35

    BACKGROUND
  • Grove K, Soccolich S, Engström J, Hanowski R. Driver visual behavior while using adaptive cruise control on commercial motor vehicles. Transportation Research Part F: Traffic Psychology and Behaviour 2019; 60: 343-52

    BACKGROUND
  • Hanowski RJ. The Naturalistic Study of Distracted Driving: Moving from Research to Practice. SAE Int J Commer Veh 2011; 4(1): 286-319

    BACKGROUND
  • Dingus TA, Klauer SG, Neale VL, et al. The 100-Car Naturalistic Driving Study: Phase II-Results of the 100-Car Field Experiment. Report DOT HS 810 593: National Highway Traffic Safety Administration, U.S. Department of Transportation; 2006

    BACKGROUND
  • AAAM's Abbreviated Injury Scale.,. 2014. https://web.archive.org/web/20140328041758/http://www.aaam.org/about-ais.html (accessed 07 September 2021.

    BACKGROUND
  • Taplin DH, Rasic M. Facilitator's source book: Sourcebook for facilitators leading theory of change development sessions. 2012. https://www.theoryofchange.org/wp-content/uploads/toco_library/pdf/ToCFacilitatorSourcebook.pdf (accessed 01 October 2021)

    BACKGROUND
  • Lockwood C, Porrit K, Munn Z, et al. Systematic reviews of qualitative evidence. In: Aromataris E, Munn Z, eds. JBI Manual for Evidence Synthesis. JBI; 2020.

    BACKGROUND
  • Green J. Effective Sexual Health Interventions: Issues In Experimental Evaluation. Sex Transm Infect 2004; 80(1): 77-8

    BACKGROUND
  • Rogers EM. Diffusion of Innovations, 5th Edition. 5th ed. Riverside: Free Press; 2003

    BACKGROUND
  • Pawson R, Tilley N, Ebscohost. Realistic evaluation. Los Angeles: Sage; 2008

    BACKGROUND
  • Westhorp G. Realist impact evaluation: an introduction. London: Overseas Development Institute.,, 2014

    BACKGROUND
  • Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Education for Information 2004; 22: 63-75

    BACKGROUND
  • Le VC, To KG, Le VD, Nguyen L, MacKenzie G, Sigwadhi LN, Piyasena P, Tran M, Chan VF, Khanna RC, Clarke M, Lohfeld L, Dickey H, Azuara-Blanco A, Mettla AL, Rayasam S, Doan HTN, Van Do D, Le PH, Klauer C, Hanowski R, Bowden Z, Murphy L, Thompson J, McMullan S, McDowell C, Narayanan R, Little JA, Ha HT, Yoon S, Goel R, Luong L, Nguyen X, Congdon N. STABLE trial of spectacle provision and driving safety among myopic motorcycle users in Vietnam: study protocol for a stepped-wedge, cluster randomised trial. Trials. 2024 Dec 18;25(1):825. doi: 10.1186/s13063-024-08644-2.

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Tô Gia Kiên, PhD

    University of Medicine and Pharmacy at Ho Chi Minh City Vietnam

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nathan G Congdon, MD, MPH

CONTACT

Rohit C Khanna, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The trial will be investigator-masked, but not participant-masked, because all participants who are eligible for eye glasses will be given them. The study's outcomes, including Crash and near Crash (CNC) events per 1,000 km, self-reported visual function (Visual Function Questionnaire (VFQ-25), and CI SRQ Crash and Injury Self report Questionnaire for all crashes, Dula Dangerous Driving Index (DDDI) will be masked from assessors. All care will be taken to ensure that the study team are kept masked and the trial team do not foresee conditions that will require emergency unmasking.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: STABLE is a naturalistic driving trial with a Stepped Wedge-Cluster Randomised Trial (SW-CRT) design. The unit of randomisation in STABLE is the cluster: five universities in Ho Chi Minh City, Vietnam. The design involves random, sequential crossover of clusters from control to intervention until all clusters are exposed to the study intervention. The stepped-wedge cohort design with exchangeable correlation structure will comprise six sequences (steps) of an estimated seven myopic participants per cluster, and five clusters per sequence. The duration of each sequence is 12 weeks. Participants will not be masked to whether they are in the control or intervention period but investigators assessing study outcomes will be masked to this.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 11, 2022

First Posted

July 20, 2022

Study Start

September 22, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

July 17, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

All Individual Participant Data (IPD) will be stored in anonymised format. The IPD that includes personal identifiable information will be deleted when the data collection process is complete and before the initiation of data analysis. Only de-identified data will be shared with all the researchers for analysis.The primary analysis will be conducted on all outcome data obtained from all enrolled participants as randomised.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
All deidentified IPD will be available from February 2023 (anticipated Trial start date) to December 2025 (inclusive of analysis, publication and archival).
Access Criteria
STABLE's research team will not provide any government with direct and unfettered access to trial participant data. Government authorities seeking access to trial data must follow applicable legal processes and supply a warrant, court order for content or a subpoena for trial data.

Locations